FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 101 through 125 of 125

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
RXRX Nasdaq Recursion Pharmaceuticals, Inc. 2834
SCPH Nasdaq scPharmaceuticals Inc. 2834
SDZNY Over the counter Sandoz Group AG 2834
SION Nasdaq Sionna Therapeutics, Inc. 2834
SLDB Nasdaq Solid Biosciences Inc. 2834
SLGL Nasdaq Sol-Gel Technologies Ltd. 2834
SLRX Nasdaq Salarius Pharmaceuticals, Inc. 2834
SNSE Nasdaq Sensei Biotherapeutics, Inc. 2834
SNY Nasdaq Sanofi 2834
SVRA Nasdaq Savara Inc. 2834
SYBX Nasdaq Synlogic, Inc. 2834
TARS Nasdaq Tarsus Pharmaceuticals, Inc. 2834
TBPH Nasdaq Theravance Biopharma, Inc. 2834
TCRT Nasdaq Alaunos Therapeutics, Inc. 2834
TELO Nasdaq Telomir Pharmaceuticals, Inc. 2834
TEVA New York Teva Pharmaceutical Industries Limited 2834
TLPH Nasdaq Talphera, Inc. 2834
TTNP Nasdaq Titan Pharmaceuticals, Inc. 2834
VTYX Nasdaq Ventyx Biosciences, Inc. 2834
WVE Nasdaq Wave Life Sciences Ltd. 2834
XBIO Nasdaq Xenetic Biosciences, Inc. 2834
XERS Nasdaq Xeris Biopharma Holdings, Inc. 2834
XRTX Nasdaq XORTX Therapeutics Inc. 2834
YCBD NYSE American cbdMD, Inc. 2834
ZYME Nasdaq Zymeworks Inc. 2834
Results 100 through 125 of 125